Sanotize Research and Development corp.
sanotize.comLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
9
Active
0
Phase 3
2
Total enrollment
2,122
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- SARS-CoV-2 Infection2
- Diabetic Foot Ulcer1
- Corona Virus Infection1
- Chronic Sinusitis1
- SARS-CoV Infection1
- Recurrent Acute Rhinosinusitis1
- Candidiasis, Oral1
- Verruca Plantaris1
Frequently asked questions about Sanotize Research and Development corp.
- How many clinical trials does Sanotize Research and Development corp. have on ClinicalTrials.gov?
- Sanotize Research and Development corp. is listed as the lead sponsor on 9 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sanotize Research and Development corp.'s trials are in Phase 3?
- 2 of Sanotize Research and Development corp.'s trials are in Phase 3.
- What therapeutic areas does Sanotize Research and Development corp. focus on?
- Sanotize Research and Development corp.'s most-studied conditions on ClinicalTrials.gov are SARS-CoV-2 Infection, Diabetic Foot Ulcer, Corona Virus Infection, Chronic Sinusitis, SARS-CoV Infection.